Key statistics
As of last trade Eton Pharmaceuticals Inc (ETON:NMQ) traded at 10.94, -1.57% below its 52-week high of 11.11, set on Nov 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.73 |
---|---|
High | 11.00 |
Low | 10.60 |
Bid | 10.89 |
Offer | 10.98 |
Previous close | 10.75 |
Average volume | 360.13k |
---|---|
Shares outstanding | 25.84m |
Free float | 24.44m |
P/E (TTM) | -- |
Market cap | 277.74m USD |
EPS (TTM) | -0.2135 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 15:21 GMT.
More ▼
- Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
- Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
- Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
- Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
- Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
- Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
- Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
- Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
More ▼